Overview Tolerance and Effect on Intraocular Pressure After Administration of SYL040012 Status: Completed Trial end date: 2010-06-01 Target enrollment: Participant gender: Summary The purpose of this study is to determine whether SYL040012 is safe for the treatment of ocular hypertension and glaucoma. Phase: Phase 1 Details Lead Sponsor: Sylentis, S.A.